{"id":"https://openalex.org/W2004359661","doi":"https://doi.org/10.1021/jm970179x","title":"Synthesis and Structure\u2212Activity Relationships of Carboxyflavones as Structurally Rigid CysLT1 (LTD4) Receptor Antagonists","display_name":"Synthesis and Structure\u2212Activity Relationships of Carboxyflavones as Structurally Rigid CysLT1 (LTD4) Receptor Antagonists","publication_year":1998,"publication_date":"1998-04-01","ids":{"openalex":"https://openalex.org/W2004359661","doi":"https://doi.org/10.1021/jm970179x","mag":"2004359661","pmid":"https://pubmed.ncbi.nlm.nih.gov/9554876"},"language":"en","primary_location":{"id":"doi:10.1021/jm970179x","doi":"https://doi.org/10.1021/jm970179x","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm970179x","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021247773","display_name":"Mari\u00ebl E. Zwaagstra","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088742","display_name":"Kowa (Japan)","ror":"https://ror.org/009z2z347","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210088742"]},{"id":"https://openalex.org/I865915315","display_name":"Vrije Universiteit Amsterdam","ror":"https://ror.org/008xxew50","country_code":"NL","type":"education","lineage":["https://openalex.org/I865915315"]}],"countries":["JP","NL"],"is_corresponding":false,"raw_author_name":"Mari\u00ebl E. Zwaagstra","raw_affiliation_strings":["Division of Medicinal Chemistry, Leiden/Amsterdam Center for Drug Research, and Department of Organic Chemistry, Vrije Universiteit, De Boelelann 1083, 1081 HV Amsterdam, The Netherlands, and Pharmaceutical Division, Tokyo Research Laboratories, Kowa Company Ltd., 2-17-43, Noguchi-Cho, Higashimurayama, Tokyo 189, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medicinal Chemistry, Leiden/Amsterdam Center for Drug Research, and Department of Organic Chemistry, Vrije Universiteit, De Boelelann 1083, 1081 HV Amsterdam, The Netherlands, and Pharmaceutical Division, Tokyo Research Laboratories, Kowa Company Ltd., 2-17-43, Noguchi-Cho, Higashimurayama, Tokyo 189, Japan","institution_ids":["https://openalex.org/I4210088742","https://openalex.org/I865915315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112783486","display_name":"Henk Timmerman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088742","display_name":"Kowa (Japan)","ror":"https://ror.org/009z2z347","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210088742"]},{"id":"https://openalex.org/I865915315","display_name":"Vrije Universiteit Amsterdam","ror":"https://ror.org/008xxew50","country_code":"NL","type":"education","lineage":["https://openalex.org/I865915315"]}],"countries":["JP","NL"],"is_corresponding":false,"raw_author_name":"Henk Timmerman","raw_affiliation_strings":["Division of Medicinal Chemistry, Leiden/Amsterdam Center for Drug Research, and Department of Organic Chemistry, Vrije Universiteit, De Boelelann 1083, 1081 HV Amsterdam, The Netherlands, and Pharmaceutical Division, Tokyo Research Laboratories, Kowa Company Ltd., 2-17-43, Noguchi-Cho, Higashimurayama, Tokyo 189, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medicinal Chemistry, Leiden/Amsterdam Center for Drug Research, and Department of Organic Chemistry, Vrije Universiteit, De Boelelann 1083, 1081 HV Amsterdam, The Netherlands, and Pharmaceutical Division, Tokyo Research Laboratories, Kowa Company Ltd., 2-17-43, Noguchi-Cho, Higashimurayama, Tokyo 189, Japan","institution_ids":["https://openalex.org/I4210088742","https://openalex.org/I865915315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036965031","display_name":"Andrea C. van de Stolpe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088742","display_name":"Kowa (Japan)","ror":"https://ror.org/009z2z347","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210088742"]},{"id":"https://openalex.org/I865915315","display_name":"Vrije Universiteit Amsterdam","ror":"https://ror.org/008xxew50","country_code":"NL","type":"education","lineage":["https://openalex.org/I865915315"]}],"countries":["JP","NL"],"is_corresponding":false,"raw_author_name":"Andrea C. van de Stolpe","raw_affiliation_strings":["Division of Medicinal Chemistry, Leiden/Amsterdam Center for Drug Research, and Department of Organic Chemistry, Vrije Universiteit, De Boelelann 1083, 1081 HV Amsterdam, The Netherlands, and Pharmaceutical Division, Tokyo Research Laboratories, Kowa Company Ltd., 2-17-43, Noguchi-Cho, Higashimurayama, Tokyo 189, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medicinal Chemistry, Leiden/Amsterdam Center for Drug Research, and Department of Organic Chemistry, Vrije Universiteit, De Boelelann 1083, 1081 HV Amsterdam, The Netherlands, and Pharmaceutical Division, Tokyo Research Laboratories, Kowa Company Ltd., 2-17-43, Noguchi-Cho, Higashimurayama, Tokyo 189, Japan","institution_ids":["https://openalex.org/I4210088742","https://openalex.org/I865915315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057602439","display_name":"Frans J. J. de Kanter","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088742","display_name":"Kowa (Japan)","ror":"https://ror.org/009z2z347","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210088742"]},{"id":"https://openalex.org/I865915315","display_name":"Vrije Universiteit Amsterdam","ror":"https://ror.org/008xxew50","country_code":"NL","type":"education","lineage":["https://openalex.org/I865915315"]}],"countries":["JP","NL"],"is_corresponding":false,"raw_author_name":"Frans J. J. de Kanter","raw_affiliation_strings":["Division of Medicinal Chemistry, Leiden/Amsterdam Center for Drug Research, and Department of Organic Chemistry, Vrije Universiteit, De Boelelann 1083, 1081 HV Amsterdam, The Netherlands, and Pharmaceutical Division, Tokyo Research Laboratories, Kowa Company Ltd., 2-17-43, Noguchi-Cho, Higashimurayama, Tokyo 189, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medicinal Chemistry, Leiden/Amsterdam Center for Drug Research, and Department of Organic Chemistry, Vrije Universiteit, De Boelelann 1083, 1081 HV Amsterdam, The Netherlands, and Pharmaceutical Division, Tokyo Research Laboratories, Kowa Company Ltd., 2-17-43, Noguchi-Cho, Higashimurayama, Tokyo 189, Japan","institution_ids":["https://openalex.org/I4210088742","https://openalex.org/I865915315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048022065","display_name":"Masahiro Tamura","orcid":"https://orcid.org/0000-0002-9721-304X","observed_orcids":["https://orcid.org/0000-0002-9721-304X"]},"institutions":[{"id":"https://openalex.org/I4210088742","display_name":"Kowa (Japan)","ror":"https://ror.org/009z2z347","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210088742"]},{"id":"https://openalex.org/I865915315","display_name":"Vrije Universiteit Amsterdam","ror":"https://ror.org/008xxew50","country_code":"NL","type":"education","lineage":["https://openalex.org/I865915315"]}],"countries":["JP","NL"],"is_corresponding":false,"raw_author_name":"Masahiro Tamura","raw_affiliation_strings":["Division of Medicinal Chemistry, Leiden/Amsterdam Center for Drug Research, and Department of Organic Chemistry, Vrije Universiteit, De Boelelann 1083, 1081 HV Amsterdam, The Netherlands, and Pharmaceutical Division, Tokyo Research Laboratories, Kowa Company Ltd., 2-17-43, Noguchi-Cho, Higashimurayama, Tokyo 189, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medicinal Chemistry, Leiden/Amsterdam Center for Drug Research, and Department of Organic Chemistry, Vrije Universiteit, De Boelelann 1083, 1081 HV Amsterdam, The Netherlands, and Pharmaceutical Division, Tokyo Research Laboratories, Kowa Company Ltd., 2-17-43, Noguchi-Cho, Higashimurayama, Tokyo 189, Japan","institution_ids":["https://openalex.org/I4210088742","https://openalex.org/I865915315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038155467","display_name":"Yasushi Wada","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088742","display_name":"Kowa (Japan)","ror":"https://ror.org/009z2z347","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210088742"]},{"id":"https://openalex.org/I865915315","display_name":"Vrije Universiteit Amsterdam","ror":"https://ror.org/008xxew50","country_code":"NL","type":"education","lineage":["https://openalex.org/I865915315"]}],"countries":["JP","NL"],"is_corresponding":false,"raw_author_name":"Yasushi Wada","raw_affiliation_strings":["Division of Medicinal Chemistry, Leiden/Amsterdam Center for Drug Research, and Department of Organic Chemistry, Vrije Universiteit, De Boelelann 1083, 1081 HV Amsterdam, The Netherlands, and Pharmaceutical Division, Tokyo Research Laboratories, Kowa Company Ltd., 2-17-43, Noguchi-Cho, Higashimurayama, Tokyo 189, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medicinal Chemistry, Leiden/Amsterdam Center for Drug Research, and Department of Organic Chemistry, Vrije Universiteit, De Boelelann 1083, 1081 HV Amsterdam, The Netherlands, and Pharmaceutical Division, Tokyo Research Laboratories, Kowa Company Ltd., 2-17-43, Noguchi-Cho, Higashimurayama, Tokyo 189, Japan","institution_ids":["https://openalex.org/I4210088742","https://openalex.org/I865915315"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5009865983","display_name":"Ming\u2010Qiang Zhang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088742","display_name":"Kowa (Japan)","ror":"https://ror.org/009z2z347","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210088742"]},{"id":"https://openalex.org/I865915315","display_name":"Vrije Universiteit Amsterdam","ror":"https://ror.org/008xxew50","country_code":"NL","type":"education","lineage":["https://openalex.org/I865915315"]}],"countries":["JP","NL"],"is_corresponding":false,"raw_author_name":"Ming-Qiang Zhang","raw_affiliation_strings":["Division of Medicinal Chemistry, Leiden/Amsterdam Center for Drug Research, and Department of Organic Chemistry, Vrije Universiteit, De Boelelann 1083, 1081 HV Amsterdam, The Netherlands, and Pharmaceutical Division, Tokyo Research Laboratories, Kowa Company Ltd., 2-17-43, Noguchi-Cho, Higashimurayama, Tokyo 189, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medicinal Chemistry, Leiden/Amsterdam Center for Drug Research, and Department of Organic Chemistry, Vrije Universiteit, De Boelelann 1083, 1081 HV Amsterdam, The Netherlands, and Pharmaceutical Division, Tokyo Research Laboratories, Kowa Company Ltd., 2-17-43, Noguchi-Cho, Higashimurayama, Tokyo 189, Japan","institution_ids":["https://openalex.org/I4210088742","https://openalex.org/I865915315"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":0.5767,"has_fulltext":false,"cited_by_count":41,"citation_normalized_percentile":{"value":0.57057674,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"41","issue":"9","first_page":"1428","last_page":"1438"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13023","display_name":"Synthesis of Organic Compounds","score":0.5609999895095825,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T13023","display_name":"Synthesis of Organic Compounds","score":0.5609999895095825,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.3483999967575073,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.01489999983459711,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cyslt1-receptor-antagonists","display_name":"CysLT1 receptor antagonists","score":0.9399999976158142},{"id":"https://openalex.org/keywords/leukotriene-d4","display_name":"leukotriene D4","score":0.8960000276565552},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.906000018119812},{"id":"https://openalex.org/keywords/quinoline-derivatives","display_name":"quinoline derivatives","score":0.7110000252723694},{"id":"https://openalex.org/keywords/rigid-ligands","display_name":"rigid ligands","score":0.4749999940395355},{"id":"https://openalex.org/keywords/tetrazoles","display_name":"tetrazoles","score":0.6809999942779541},{"id":"https://openalex.org/keywords/flavone-synthesis","display_name":"flavone synthesis","score":0.5460000038146973}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9159542322158813},{"id":"https://openalex.org/C2776309666","wikidata":"https://www.wikidata.org/wiki/Q408384","display_name":"Quinoline","level":2,"score":0.8097163438796997},{"id":"https://openalex.org/C2776568683","wikidata":"https://www.wikidata.org/wiki/Q23005640","display_name":"Moiety","level":2,"score":0.7976638078689575},{"id":"https://openalex.org/C2776292868","wikidata":"https://www.wikidata.org/wiki/Q424525","display_name":"Flavones","level":2,"score":0.7826183438301086},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.7752876281738281},{"id":"https://openalex.org/C2780283098","wikidata":"https://www.wikidata.org/wiki/Q4688960","display_name":"Affinities","level":2,"score":0.7586387991905212},{"id":"https://openalex.org/C2780557392","wikidata":"https://www.wikidata.org/wiki/Q523796","display_name":"Linker","level":2,"score":0.5841456055641174},{"id":"https://openalex.org/C193042331","wikidata":"https://www.wikidata.org/wiki/Q1772003","display_name":"Structure\u2013activity relationship","level":3,"score":0.5029162764549255},{"id":"https://openalex.org/C2780827033","wikidata":"https://www.wikidata.org/wiki/Q58826308","display_name":"Tetrazole","level":2,"score":0.4568345248699188},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.4445136785507202},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.42267102003097534},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.20458701252937317},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.11039215326309204},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.07597929239273071},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.0},{"id":"https://openalex.org/C111919701","wikidata":"https://www.wikidata.org/wiki/Q9135","display_name":"Operating system","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005419","descriptor_name":"Flavonoids","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D005419","descriptor_name":"Flavonoids","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005419","descriptor_name":"Flavonoids","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005419","descriptor_name":"Flavonoids","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D006168","descriptor_name":"Guinea Pigs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007082","descriptor_name":"Ileum","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D007082","descriptor_name":"Ileum","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D008168","descriptor_name":"Lung","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008168","descriptor_name":"Lung","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008565","descriptor_name":"Membrane Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D009119","descriptor_name":"Muscle Contraction","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009130","descriptor_name":"Muscle, Smooth","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009130","descriptor_name":"Muscle, Smooth","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D011804","descriptor_name":"Quinolines","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D011804","descriptor_name":"Quinolines","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011804","descriptor_name":"Quinolines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011804","descriptor_name":"Quinolines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017998","descriptor_name":"Leukotriene D4","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D017998","descriptor_name":"Leukotriene D4","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018077","descriptor_name":"Receptors, Leukotriene","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018927","descriptor_name":"Anti-Asthmatic Agents","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D018927","descriptor_name":"Anti-Asthmatic Agents","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018927","descriptor_name":"Anti-Asthmatic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018927","descriptor_name":"Anti-Asthmatic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D020024","descriptor_name":"Leukotriene Antagonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D066298","descriptor_name":"In Vitro Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1021/jm970179x","doi":"https://doi.org/10.1021/jm970179x","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm970179x","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:9554876","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9554876","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medicinal chemistry","raw_type":"Comparative Study"},{"id":"pmh:oai:research.vu.nl:openaire_cris_publications/d141020a-203d-494b-bd10-8ef0570e33e2","doi":null,"is_oa":false,"landing_page_url":"https://research.vu.nl/en/publications/d141020a-203d-494b-bd10-8ef0570e33e2","pdf_url":null,"source":{"id":"https://openalex.org/S4306401107","display_name":"VU Research Portal","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I865915315","host_organization_name":"Vrije Universiteit Amsterdam","host_organization_lineage":["https://openalex.org/I865915315"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Zwaagstra, M E, Timmerman, H, Stolpe, A C, de Kanter, F J J, Tamura, M, Wada, Y & Zhang, M Q 1998, 'Synthesis and structure-activity relationships of carboxyflavones as structurally rigid CysLT1 (LTD4) receptor antagonists.', Journal of Medicinal Chemistry, vol. 41, pp. 1428-1438. https://doi.org/10.1021/jm970179x","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:dare.ubvu.vu.nl:1871/24955","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/1871/24955","pdf_url":null,"source":{"id":"https://openalex.org/S4306400546","display_name":"Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I865915315","host_organization_name":"Vrije Universiteit Amsterdam","host_organization_lineage":["https://openalex.org/I865915315"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"41","raw_type":"Article / Letter to editor"},{"id":"pmh:vu:oai:research.vu.nl:publications/d141020a-203d-494b-bd10-8ef0570e33e2","doi":null,"is_oa":false,"landing_page_url":"https://research.vu.nl/en/publications/d141020a-203d-494b-bd10-8ef0570e33e2","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Medicinal Chemistry, 41, 1428 - 1438. American Chemical Society","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":34,"referenced_works":["https://openalex.org/W642666269","https://openalex.org/W1520307434","https://openalex.org/W1968624262","https://openalex.org/W1973679985","https://openalex.org/W1976554063","https://openalex.org/W1992571653","https://openalex.org/W1996425731","https://openalex.org/W1999977880","https://openalex.org/W2004351423","https://openalex.org/W2007207481","https://openalex.org/W2008867153","https://openalex.org/W2014677805","https://openalex.org/W2014982517","https://openalex.org/W2017358854","https://openalex.org/W2029697811","https://openalex.org/W2042315775","https://openalex.org/W2044927863","https://openalex.org/W2050444360","https://openalex.org/W2059903613","https://openalex.org/W2072506509","https://openalex.org/W2072568796","https://openalex.org/W2074633647","https://openalex.org/W2075247609","https://openalex.org/W2080663864","https://openalex.org/W2086752638","https://openalex.org/W2088603842","https://openalex.org/W2089011069","https://openalex.org/W2122329227","https://openalex.org/W2399190690","https://openalex.org/W2955354409","https://openalex.org/W4213025950","https://openalex.org/W4237326913","https://openalex.org/W4241161331","https://openalex.org/W4323915196"],"related_works":["https://openalex.org/W2399190690","https://openalex.org/W1985070004","https://openalex.org/W2949764694","https://openalex.org/W2050444360","https://openalex.org/W2016635231","https://openalex.org/W2133593302","https://openalex.org/W2020249378","https://openalex.org/W2615200592","https://openalex.org/W2952526806","https://openalex.org/W2041950939"],"abstract_inverted_index":{"The":[0,99,204],"synthesis":[1],"and":[2,14,18,65,92,158,210,244],"CysLT1":[3,27,72,141,180,238,253],"receptor":[4,28,47,181,239],"affinities":[5,29,182],"of":[6,10,30,61,144,183,190,198,224,251],"a":[7,113,252],"new":[8],"series":[9,233],"highly":[11],"rigid":[12,237],"3'-":[13,17],"4'-(2-quinolinylmethoxy)-":[15],"or":[16,22,112,164],"4'-[2-(2-quinolinyl)ethenyl]-substituted,":[19],"6-,":[20],"7-,":[21],"8-carboxylated":[23],"flavones":[24,32],"are":[25,132,246],"described.":[26],"the":[31,58,62,66,75,80,86,90,94,106,117,127,136,145,156,168,176,195,229,235,249,260],"(down":[33],"to":[34,42,105,152,175,242],"11":[35],"nM)":[36],"were":[37,69,186],"determined":[38],"by":[39,109,147],"their":[40,191],"ability":[41],"displace":[43],"[3H]LTD4":[44],"from":[45],"its":[46,225],"in":[48,79,85,126,173,202,228,248,259],"guinea":[49,199],"pig":[50,200],"lung":[51],"membranes.":[52],"Structure-affinity":[53],"relationship":[54],"studies":[55],"showed":[56],"that":[57],"relative":[59],"positions":[60],"carboxylic":[63],"acid":[64],"quinoline":[67,100,146],"moiety":[68,101],"critical":[70],"for":[71,122,188,220],"affinities.":[73],"While":[74],"carboxyl":[76],"is":[77,120,171,257],"optimal":[78],"8":[81],"position":[82,119],"but":[83,116],"tolerated":[84],"6":[87],"position,":[88],"only":[89,162],"6-":[91],"not":[93],"8-tetrazole":[95],"has":[96],"significant":[97],"activity.":[98],"may":[102],"be":[103],"connected":[104],"flavone":[107],"skeleton":[108],"an":[110],"ethenyl":[111],"methoxy":[114],"linker,":[115],"substitution":[118],"important":[121],"high":[123,226],"affinity,":[124,166],"especially":[125],"6-carboxylated":[128],"flavones.":[129],"4'-Substituted":[130],"6-carboxyflavones":[131],"essentially":[133],"inactive,":[134],"whereas":[135],"3'-substituted":[137],"analogues":[138,160],"have":[139],"submicromolar":[140],"affinity.":[142],"Replacement":[143],"other":[148],"heteroaromates":[149],"generally":[150],"leads":[151],"decreased":[153],"affinities,":[154],"with":[155],"phenyl":[157],"naphthyl":[159],"displaying":[161],"little":[163],"no":[165],"while":[167],"7-chloroquinoline":[169],"analogue":[170],"comparable":[172],"activity":[174],"quinoline.":[177],"Flavones":[178],"having":[179],"10-30":[184],"nM":[185],"selected":[187,219],"determination":[189],"inhibitory":[192],"effects":[193],"on":[194],"LTD4-induced":[196],"contraction":[197],"ileum":[201],"vitro.":[203],"IC50":[205],"values":[206],"ranged":[207],"between":[208],"15":[209],"100":[211],"nM.":[212],"Compound":[213],"5d":[214],"(8-carboxy-6-chloro-3'-(2-quinolinylmethoxy)flavone,":[215],"VUF":[216],"5087)":[217],"was":[218],"further":[221],"research":[222],"because":[223],"potency":[227],"functional":[230],"assay.":[231],"This":[232],"contains":[234],"most":[236],"antagonists":[240],"known":[241],"date,":[243],"they":[245],"useful":[247],"development":[250],"antagonist":[254],"model,":[255],"which":[256],"discussed":[258],"companion":[261],"paper.":[262]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}